Codexis (CDXS) Gains from Investment Securities (2011 - 2025)
Codexis (CDXS) recorded quarterly Gains from Investment Securities of $300000.0 in Q4 2025, up 50.0% quarter-over-quarter from $200000.0 in Q4 2024, and up 50.0% on a YoY basis from $200000.0 in Q4 2024.
Codexis (CDXS) Gains from Investment Securities (2011 - 2025) Analysis & Trends
Codexis' Gains from Investment Securities history runs 15 years deep, the most recent figure standing at $300000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 50.0% year-over-year to $300000.0; the TTM figure through Dec 2025 stood at $4.4 million (up 7.32% YoY), while the FY2025 annual figure was $300000.0, changed N/A from the prior year.
- Gains from Investment Securities was $300000.0 for Q4 2025 at Codexis, up from $200000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.0 million in Q3 2021 to a low of -$5.7 million in Q4 2021.
- Historically, Gains from Investment Securities has averaged $969125.0 across 5 years, with a median of $250000.0 in 2024.
- The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities surged 814.29% in 2021, then sank 2796.75% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at -$5.7 million in 2021, then surged by 193.39% to $5.3 million in 2022, then tumbled by 77.36% to $1.2 million in 2023, then sank by 83.33% to $200000.0 in 2024, then surged by 50.0% to $300000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $300000.0 (Q4 2025), $200000.0 (Q4 2024), and $3.9 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | -396,000.00 |
| Jun 30, 2023 | -396,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 5.30 Mn |
| Dec 31, 2022 | 5.30 Mn |